Publication: Phase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC)
Program
KU-Authors
KU Authors
Co-Authors
Nomak, G.
Oksuzoglu, B.
Senturk, R.
Eralp, Y.
Nomak, H.
Sanyal, R.
Advisor
Publication Date
Language
English
Type
Journal Title
Journal ISSN
Volume Title
Abstract
N/A
Source:
Annals of Oncology
Publisher:
Elsevier
Keywords:
Subject
Oncology